Acceleron Pharma Reports Second Quarter 2016 Financial and Operational Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. CVS
7. UNH
8. DAL
9. TMUS
10. VZ

Go back to Acceleron Pharma Reports Second Quarter 2016 Financial and Operational Results

Acceleron Pharma (XLRN) Misses Q2 EPS by 9c

August 4, 2016 8:09 AM EDT

Acceleron Pharma (NASDAQ: XLRN) reported Q2 EPS of ($0.59), $0.09 worse than the analyst estimate of ($0.50). Revenue for the quarter came in at $3.2 million versus the consensus estimate of $3.77 million.

Cash, cash equivalents and investments as of June 30, 2016 were $262.7 million. As of December 31, 2015 the Company had... More